A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

NCT05951192 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

161

Enrollment

NETWORK

Sponsor class

Conditions

Anemia
Renal Insufficiency, Chronic
Renal Anemia

Interventions

DRUG: Daprodustat

Sponsor

USRC Kidney Research

Collaborators

[object Object]